Form 8-K
8-K — National Healthcare Properties, Inc.
Accession: 0001140361-26-043036
Filed: 2026-11-10
Period: 2026-11-10
CIK: 0001561032
SIC: 6798 (REAL ESTATE INVESTMENT TRUSTS)
Item: Other Events
Item: Financial Statements and Exhibits
Documents
8-K — ef20085156_8k.htm (Primary)
EX-99.1 — EXHIBIT 99.1 (ef20085156_ex99-1.htm)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K
8-K (Primary)
Filename: ef20085156_8k.htm · Sequence: 1
false000156103200015610322026-11-102026-11-10
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 10, 2026
National Healthcare Properties, Inc.
(Exact name of Registrant as Specified in its Charter)
Maryland
001-39153
38-3888962
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
540 Madison Ave., 27th Floor
New York, NY 10022
(Address of Principal Executive Offices, including Zip Code)
Registrant’s telephone number, including area code: (332) 258-8770
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange on which
registered
Common stock, $0.01 par value per share
NHP
The Nasdaq Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new
or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01
Other Events.
Pro Forma Financial Information of Completed and Probable Acquisitions of SHOP Communities
From January 1, 2026 through September 30, 2026, National Healthcare
Properties, Inc. (the “Company”), through subsidiaries of National Healthcare Properties Operating Partnership, L.P. (the “Operating Partnership”), completed the acquisitions of 24 senior housing operating portfolio (“SHOP”) communities in
several separate transactions. In addition, the Company expects to complete the acquisitions of several additional SHOP communities during the fourth quarter of 2026 or first quarter of 2027, which the Company considers to be probable (the completed and probable acquisitions of SHOP communities collectively, the “Acquisitions”).
None of the Acquisitions is individually significant to the Company under Regulation S-X, and as such, no separate financial statements of any acquired or to be acquired
SHOP communities are required to be filed. However, because the aggregate impact of the Acquisitions exceeds 50% under Regulation S-X, the Company is filing the Pro Forma Financial Information (as defined below) that gives effect to the aggregate
impact of the Acquisitions, which is filed as Exhibit 99.1 to this Current Report on Form 8-K (this “Current Report”).
Pro Forma Financial Information of Probable Disposition of OMFs
As previously reported in the Company’s Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the “SEC”)
on September 29, 2026, certain subsidiaries of the Company are party to a purchase and sale agreement, dated as of July 15, 2026 (as amended from time to time, the “PSA”), with an unaffiliated third party (the “Purchaser”), pursuant to which such
subsidiaries agreed to sell the Company’s portfolio of 40 outpatient medical facilities (“OMFs”) for an aggregate purchase price of approximately $531 million, before transaction expenses, property operating prorations, capital expenditure credits
and other adjustments (the “Disposition”). The PSA contains customary representations, warranties and covenants of the parties, as well as customary post-closing obligations. The Disposition is expected to close during the fourth quarter of 2026,
subject to the satisfaction or waiver of customary closing conditions specified in the PSA.
Because the Disposition exceeds 20% significance under Rule 11-01(b) of Regulation S-X, the Disposition constitutes the probable
disposition of a significant portion of the Company’s business under Rule 11-01(a)(4) of Regulation S-X, and the Company is filing the Pro Forma Financial Information that gives effect to the Disposition, which is filed as Exhibit 99.1 to this
Current Report.
Although the Disposition and the probable Acquisitions are reflected in the Pro Forma Financial Information as probable transactions,
no assurance can be given that any of these transactions will be completed on the terms described herein or at all. The closing of the Disposition is subject to the satisfaction or waiver of customary closing conditions specified in the PSA, and
the closing of each probable Acquisition is subject to the satisfaction or waiver of the closing conditions specified in the applicable purchase agreement.
The unaudited pro forma condensed combined financial information of the Company giving effect to the Acquisitions and the Disposition
(the “Pro Forma Financial Information”) consists of the unaudited pro forma condensed combined balance sheet as of September 30, 2026, the unaudited pro forma condensed combined statements of operations for the nine months ended September 30, 2026
and for the year ended December 31, 2025, and the notes thereto. The unaudited pro forma condensed combined balance sheet of the Company as of September 30, 2026 gives effect to the probable Acquisitions and the Disposition as if each had occurred
on September 30, 2026. The SHOP communities acquired on or before September 30, 2026 are reflected in the Company’s historical condensed consolidated balance sheet as of that date. The unaudited pro forma condensed combined statements of operations
of the Company for the nine months ended September 30, 2026 and for the year ended December 31, 2025 give effect to the Acquisitions and the Disposition as if each had occurred on January 1, 2025. Such unaudited pro forma condensed combined
statements of operations do not:
(i)
fully reflect the disposition of 30 OMFs completed on September 10, 2026, as disclosed in the Company’s Current Report on Form 8-K filed with the SEC on September 10, 2026,
which OMFs generated approximately $13.5 million and $26.3 million of aggregate rental revenue from tenants during the nine months ended September 30, 2026 and the year ended December 31, 2025, respectively; or
(ii)
reflect the separate pending disposition of 56 OMFs currently under contract, as disclosed in the Company’s Current Report on Form 8-K filed with the SEC on May 8, 2026,
which OMFs generated approximately $27.2 million and $36.6 million of aggregate rental revenue from tenants during the nine months ended September 30, 2026 and the year ended December 31, 2025, respectively.
The Pro Forma Financial Information has been prepared in accordance with Article 11 of Regulation S-X, is filed as Exhibit 99.1 to this Current Report and
is incorporated herein by reference.
The Pro Forma Financial Information is based upon available information and assumptions that the Company considers reasonable and is
provided for informational purposes only. It does not purport to represent what the Company’s actual financial position or results of operations would have been had the Acquisitions and the Disposition occurred on the dates assumed, nor is it
necessarily indicative of the Company’s future financial position or results of operations. Differences between the pro forma adjustments and the final accounting for the Acquisitions and the Disposition may be material. The Pro Forma Financial
Information should be read in conjunction with (i) the accompanying notes thereto, (ii) the audited consolidated financial statements and accompanying notes of the Company contained in its Annual Report on Form 10-K for the year ended December 31,
2025, filed with the SEC on February 20, 2026, and (iii) the unaudited condensed consolidated financial statements and accompanying notes of the Company contained in its Quarterly Report on Form 10-Q for the quarterly period ended September 30,
2026, filed with the SEC on November 5, 2026.
This Current Report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended, including statements regarding the expected timing and completion of the probable Acquisitions and the Disposition. Words such as “expects,” “anticipates,” “intends,” “believes,” “may,” “will,”
“probable” and similar expressions are intended to identify forward-looking statements. These statements are based on the Company’s current expectations and are subject to risks and uncertainties, including the risk that the conditions to closing
of any of these transactions are not satisfied or waived, that any of these transactions is not completed on the anticipated terms or timeline or at all, and the other risks described under “Risk Factors” in the Company’s Annual Report on Form 10-K
for the year ended December 31, 2025 and subsequent filings with the SEC. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements speak only as of the date of this Current
Report, and the Company undertakes no obligation to update or revise them, except as required by law.
Item 9.01
Financial Statements and Exhibits.
(b) Pro Forma Financial Information.
The Pro Forma Financial Information of the Company giving effect to the Acquisitions and the Disposition, consisting of the unaudited
pro forma condensed combined balance sheet as of September 30, 2026, the unaudited pro forma condensed combined statements of operations for the nine months ended September 30, 2026 and for the year ended December 31, 2025, and the notes thereto,
is filed as Exhibit 99.1 to this Current Report and is incorporated herein by reference.
The information under Item 8.01 of this Current Report is also incorporated herein by reference.
(d) Exhibits.
Exhibit
Number
Description
99.1
Unaudited pro forma condensed combined financial information of National Healthcare Properties, Inc. as of September 30, 2026 and for the nine months ended
September 30, 2026 and the year ended December 31, 2025
104
Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
NATIONAL HEALTHCARE PROPERTIES, INC.
Date:
November 10, 2026
By:
/s/ Andrew T. Babin
Name:
Andrew T. Babin
Title:
Chief Financial Officer and Treasurer
EX-99.1 — EXHIBIT 99.1
EX-99.1
Filename: ef20085156_ex99-1.htm · Sequence: 2
Exhibit 99.1
NATIONAL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES
Unaudited Pro Forma Condensed Combined Financial Information
(in thousands)
National Healthcare Properties, Inc. (including, as by context, National Healthcare Properties Operating Partnership, L.P. (the “OP”) and its
subsidiaries, the “Company”) completed the acquisition of 24 senior housing operating properties (“SHOP”) during the period from January 1, 2026 through September 30, 2026. The Company expects to close the acquisitions of eight additional SHOP
during the fourth quarter of 2026, and the Company considers these acquisitions to be probable. Each of the completed and probable acquisitions, (collectively, the “Acquisitions”) was individually insignificant; however, the aggregate impact
of the Acquisitions exceeded the significance threshold under Regulation S-X of the Securities and Exchange Commission (the “SEC”).
On July 15, 2026, certain subsidiaries of the Company entered into a purchase and sale agreement, as amended from time to time (the “PSA”) with an
unaffiliated third party to sell the Company’s portfolio of 40 outpatient medical facilities (the “OMF Portfolio”) for approximately $531.4 million before transaction expenses, property operating prorations and capital expenditure and other adjustments (the transactions contemplated thereunder, the “Disposition”). The PSA
contains customary representations and warranties made by the parties thereto, customary covenants and agreements and customary post-closing obligations of the purchaser. The Disposition is expected to close in the fourth quarter of 2026, subject to
customary closing conditions as specified in the PSA.
The following unaudited pro forma condensed combined financial information has been prepared in accordance with Article 11 of Regulation S-X. The
unaudited pro forma condensed combined financial information of the Company as of and for the nine months ended September 30, 2026 and for the year ended December 31, 2025 has been derived from (1) the historical audited consolidated financial
statements of the Company included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 20, 2026; (2) the historical unaudited condensed consolidated financial statements of the Company
included in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, filed with the SEC on November 5, 2026; and (3) certain historical unaudited financial information, including revenue and expense information, from the
Company’s accounting books and records with respect to the Disposition and from supporting documentation related to the Acquisitions.
The unaudited pro forma condensed combined balance sheet as of September 30, 2026 gives effect to the probable SHOP acquisitions and the Disposition
subsequent to September 30, 2026 as if each had occurred on September 30, 2026. The SHOP acquisitions completed on or before September 30, 2026 are already reflected in the Company’s historical condensed consolidated balance sheet as of that date.
The unaudited pro forma condensed combined statements of operations for the nine months ended September 30, 2026 and for the year ended December 31, 2025
give effect to the Acquisitions and the Disposition as if each had occurred on January 1, 2025.
1
The following table summarizes the Acquisitions reflected in the accompanying unaudited pro forma condensed combined financial information (dollars in
thousands):
Acquisitions
Number of
properties
Acquisition date
Purchase price
Midwest Portfolio
2
June 30, 2026
$
99,098
Addington Place of Cape Coral
1
July 1, 2026
35,160
Discovery Portfolio
13
July 6, 2026
65,377
Addington Place of Canfield
1
July 15, 2026
26,740
River Glen of St. Charles
1
July 15, 2026
40,605
Addington Place of Spirit Lake
1
July 30, 2026
16,006
Central IL Portfolio
3
August 14, 2026
30,698
Sonata Portfolio
2
August 31, 2026
90,306
Crestview Senior Living
1
October 30, 2026
25,755
Inspired Portfolio
5
Estimated Q4 2026
148,670
Maine Portfolio
2
Estimated Q4 2026
49,995
Total purchase price
$
628,410
The unaudited pro forma adjustments are based on available information and assumptions that the Company considers reasonable and supportable. The
unaudited pro forma condensed combined financial information is prepared for informational purposes only and is not necessarily indicative of what the Company’s actual financial position or results of operations would have been had the Acquisitions
and the Disposition been completed as of the dates indicated, nor does it purport to represent the Company’s future financial position or results of operations. Because the unaudited pro forma condensed combined financial information has been
prepared based on these assumptions, the final amounts recorded to reflect the accounting for the Acquisitions and the Disposition may differ materially from the information presented herein.
2
NATIONAL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES
Unaudited Pro Forma Condensed Combined Balance Sheet
As of September 30, 2026
(In thousands)
Company (Historical)
Note (2.A)
Pro forma Acquisitions
Note(2.B)
Pro forma Disposition
Note (2.C)
Company pro forma
ASSETS
Real estate investments, at cost:
Land
$
168,716
$
11,899
$
(31,719
)
$
148,896
Buildings, fixtures and improvements
1,893,128
192,708
(435,424
)
1,650,412
Acquired intangible lease assets
235,245
19,813
(75,514
)
179,544
Construction in progress
4,889
—
(2,298
)
2,591
Total real estate investments, at cost
2,301,978
224,420
(544,955
)
1,981,443
Less: accumulated depreciation and amortization
(627,462
)
—
189,888
(437,574
)
Total real estate investments, net
1,674,516
224,420
(355,067
)
1,543,869
Cash and cash equivalents
125,069
(224,420
)
507,938
408,587
Restricted cash
18,966
—
—
18,966
Derivative assets, at fair value
9,936
—
—
9,936
Straight-line rent receivable, net
18,048
—
—
18,048
Operating lease right-of-use assets
13,941
—
(4,286
)
9,655
Prepaid expenses and other assets, net
25,798
—
—
25,798
Accounts receivable, net
9,702
—
—
9,702
Deferred costs, net
18,839
—
(8,570
)
10,269
Total assets
$
1,914,815
$
—
$
140,015
$
2,054,830
LIABILITIES AND EQUITY
Liabilities
Mortgage notes payable, net
$
249,581
$
—
$
—
$
249,581
Revolving credit facility
305,000
—
—
305,000
Term loan, net
296,661
—
—
296,661
Market lease intangible liabilities, net
4,002
—
(2,828
)
1,174
Accounts payable and accrued expenses
121,053
—
(4,259
)
116,794
Operating lease liabilities
8,205
—
(4,406
)
3,799
Deferred rent
7,898
—
—
7,898
Distributions payable
1,340
—
—
1,340
Total liabilities
993,740
—
(11,493
)
982,247
Commitments and Contingencies
Equity
7.375% Series A cumulative redeemable perpetual preferred stock, $0.01 par value, — authorized as of
September 30, 2026; — issued and outstanding as of September 30, 2026
—
—
—
—
7.125% Series B cumulative redeemable perpetual preferred stock, $0.01 par value, 2,900 authorized as of
September 30, 2026; 2,850 issued and outstanding as of September 30, 2026
—
—
—
—
Common stock, $0.01 par value, 300,000 shares authorized, 28,638 shares issued and outstanding as of
September 30, 2026
1,132
—
—
1,132
Class A common stock, $0.01 par value, 100,000 authorized as of September 30, 2026; 44,275 issued and
outstanding as of September 30, 2026
443
—
—
443
Additional paid-in capital
2,849,755
—
—
2,849,755
Accumulated other comprehensive income (loss)
8,420
—
—
8,420
Distributions in excess of accumulated earnings
(1,941,567
)
—
151,508
(1,790,059
)
Total stockholders' equity
918,183
—
151,508
1,069,691
Non-controlling interests
2,892
—
—
2,892
Total equity
921,075
—
151,508
1,072,583
Total liabilities and equity
$
1,914,815
$
—
$
140,015
$
2,054,830
The accompanying notes are an integral part of this unaudited pro forma condensed combined financial information.
3
NATIONAL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES
Unaudited Pro Forma Condensed Combined Statement of Operations
For the Nine Months Ended September 30, 2026
(In thousands, except per share data)
Company (Historical)
Note (3.A)
Pro forma Acquisitions
Note (3.B)
Pro forma Disposition
Note (3.C)
Transaction accounting adjustments
Notes
Company pro forma
Revenue from tenants
$
276,877
$
103,402
$
(38,553
)
$
63
(3.D)
$
341,789
Operating expenses:
Property operating and maintenance
176,613
78,535
(9,701
)
—
245,447
Impairment charges
10,654
—
—
—
10,654
Acquisition and transaction related
1,058
—
(8
)
—
1,050
General and administrative
19,877
—
(14
)
—
19,863
Depreciation and amortization
59,966
—
(11,894
)
9,159
(3.E)
57,231
Total expenses
268,168
78,535
(21,617
)
9,159
334,245
Operating income (loss) before gain on sale of real estate investments
8,709
24,867
(16,936
)
(9,096
)
7,544
Gain on sale of real estate investments
38,296
—
—
—
38,296
Operating income (loss)
47,005
24,867
(16,936
)
(9,096
)
45,840
Other income (expense):
Interest expense
(39,553
)
—
(9
)
—
(39,562
)
Interest and other income, net
3,497
—
—
—
3,497
(Loss) gain on extinguishment of debt
(427
)
—
—
—
(427
)
Gain (loss) on non-designated derivatives
78
—
—
—
78
Total other expenses, net
(36,405
)
—
(9
)
—
(36,414
)
Income (loss) before income taxes
10,600
24,867
(16,945
)
(9,096
)
9,426
Income tax expense
(27
)
—
—
(27
)
Net income (loss)
10,573
24,867
(16,945
)
(9,096
)
9,399
Net income attributable to non-controlling interests
(59
)
—
—
—
(59
)
Allocation for preferred stock
(8,480
)
—
—
—
(8,480
)
Net income (loss) attributable to common stockholders
2,034
24,867
(16,945
)
(9,096
)
860
Other comprehensive income (loss):
Unrealized income (loss) on designated derivatives
2,816
—
—
—
2,816
Comprehensive income (loss) attributable to common stockholders
$
4,850
$
24,867
$
(16,945
)
$
(9,096
)
$
3,676
Denominator for basic net income (loss) attributable to common stockholders per share — weighted-average
shares
54,347
54,347
Denominator for diluted net income (loss) attributable to common stockholders per share — weighted-average
shares
54,754
54,754
Net Income (loss) attributable to common stockholders per common share – Basic
$
0.04
$
0.02
Net Income (loss) attributable to common stockholders per common share – Diluted
$
0.04
$
0.02
The accompanying notes are an integral part of this unaudited pro forma condensed combined financial information.
4
NATIONAL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES
Unaudited Pro Forma Condensed Combined Statement of Operations
For the Year Ended December 31, 2025
(In thousands, except per share data)
Company (Historical)
Note (3.A)
Pro forma Acquisitions
Note (3.B)
Pro forma Disposition
Note (3.C)
Notes
Transaction accounting adjustments
Notes
Company pro forma
Revenue from tenants
$
342,279
$
155,637
$
(50,168
)
$
108
(3.D)
$
447,856
Operating expenses:
Property operating and maintenance
218,898
115,732
(12,562
)
—
322,068
Impairment charges
44,914
—
—
—
44,914
Acquisition and transaction related
516
—
—
—
516
General and administrative
24,190
—
—
—
24,190
Depreciation and amortization
78,261
—
(16,143
)
59,921
(3.E)
122,039
Total expenses
366,779
115,732
(28,705
)
59,921
513,727
Operating income (loss) before gain on sale of real estate investments
(24,500
)
39,905
(21,463
)
(59,813
)
(65,871
)
Gain on sale of real estate investments
27,800
—
151,508
(3.F)
—
179,308
Operating income (loss)
3,300
39,905
130,045
(59,813
)
113,437
Other income (expense):
Interest expense
(61,281
)
—
71
—
(61,210
)
Interest and other income, net
272
—
—
—
272
(Loss) gain on extinguishment of debt
257
—
—
—
257
Gain (loss) on non-designated derivatives
(72
)
—
—
—
(72
)
Total other expenses, net
(60,824
)
—
71
—
(60,753
)
Income (loss) before income taxes
(57,524
)
39,905
130,116
(59,813
)
52,684
Income tax expense
(161
)
—
—
—
(161
)
Net income (loss)
(57,685
)
39,905
130,116
(59,813
)
52,523
Net income attributable to non-controlling interests
64
—
—
—
64
Allocation for preferred stock
(13,446
)
—
—
—
(13,446
)
Net income (loss) attributable to common stockholders
(71,067
)
39,905
130,116
(59,813
)
39,141
Other comprehensive income (loss):
Unrealized income (loss) on designated derivatives
(11,036
)
—
—
—
(11,036
)
Comprehensive income (loss) attributable to common stockholders
$
(82,103
)
$
39,905
$
130,116
$
(59,813
)
$
28,105
Denominator for basic net income (loss) attributable to common stockholders per share — weighted-average
shares
28,304
28,304
Denominator for diluted net income (loss) attributable to common stockholders per share — weighted-average
shares
28,554
28,554
Net income (loss) attributable to common stockholders per common share – Basic
$
(2.51
)
$
1.38
Net income (loss) attributable to common stockholders per common share – Diluted
$
(2.51
)
$
1.37
The accompanying notes are an integral part of this unaudited pro forma condensed combined financial information.
5
NATIONAL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES
Notes to Unaudited Pro Forma Condensed Combined Financial Statements
(In thousands, except per share data)
Note 1. Basis of Presentation
The pro forma financial information is meant to illustrate the pro forma condensed combined balance sheet and the pro forma condensed combined statements
of operations of the Company, following the completion of the Acquisitions and the Disposition. The historical financial statements of the Company were prepared in accordance with accounting principles generally accepted in the United States of
America and presented in U.S. dollars.
The pro forma financial information includes adjustments to reflect the accounting for the Acquisitions as asset acquisitions in accordance with
Accounting Standards Codification (“ASC”) Subtopic 805-50, Business Combinations
– Related Issues (“ASC 805”).
The pro forma financial information also includes adjustments to reflect the accounting for the Disposition, including recognition of the estimated gain
on sale.
Note 2. Adjustments to Pro Forma Balance Sheet
(2.A) Reflects the historical assets,
liabilities and stockholders’ equity of the Company as filed in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026.
(2.B) Represents the accounting of the probable
acquisitions of Crestview Senior Living, the Inspired Portfolio and the Maine Portfolio as asset acquisitions under ASC 805. The probable acquisitions are assumed to be funded with cash on hand and proceeds from the Disposition. These pro forma
adjustments reflect the aggregated cash purchase price of $224.4 million, inclusive of $2.2 million of estimated transaction costs, and the estimated allocation of the purchase price based on relative fair value to the acquired assets as follows
(dollars in thousands):
Account
Crestview Senior
Living
Inspired Portfolio
Maine Portfolio
Total probable
acquisitions
Land
$
1,313
$
8,088
$
2,498
$
11,899
Buildings, fixtures and improvements
20,474
134,109
38,125
192,708
Acquired intangible lease assets
3,968
6,473
9,372
19,813
Total consideration transferred
$
25,755
$
148,670
$
49,995
$
224,420
(2.C) Represents the removal of the net assets
of the probable Disposition and the recognition of the gain on sale. The pro forma adjustment to cash is calculated as follows (dollars in thousands):
Net cash consideration
Amount
Estimated gross proceeds from the Disposition
$
531,438
Seller capital expenditure credits
(20,000
)
Estimated closing costs
(3,500
)
Pro forma adjustment to Cash and cash equivalents
$
507,938
6
The difference between the net cash consideration of $507.9 million
and the net book value of the disposal group of $356.4 million results in an estimated gain on sale of the OMF Portfolio of $151.5 million, which is reflected within the pro forma statement of operations for the year ended December 31, 2025.
The Company expects to use the proceeds from the Disposition to fund future acquisitions and for general corporate purposes.
7
Note 3. Adjustments to Pro Forma Statements of Operations
(3.A) Reflects the consolidated results of operations of the
Company as filed in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026 and the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.
(3.B) Represents the unaudited pro forma historical revenue and
certain operating expense information by property derived from the seller’s accounting books and records.
The unaudited pro forma historical revenue and certain operating expense information for the nine months ended September 30, 2026 are comprised of the
following (dollars in thousands):
Nine months ended September 30, 2026
Acquisitions
Revenues
Total Expenses
Midwest Portfolio
$
9,693
$
6,422
Addington Place of Cape Coral
4,046
3,235
Addington Place of Canfield
3,529
2,720
Discovery Portfolio
18,159
15,406
River Glen of St. Charles
5,260
3,557
Addington Place of Spirit Lake
2,750
2,173
Central IL Portfolio
7,878
6,461
Sonata Portfolio
10,685
6,192
Inspired Portfolio
25,787
18,870
Crestview Senior Living
5,331
3,640
Maine Portfolio
10,284
9,859
Total pro forma revenues and expenses
$
103,402
$
78,535
8
The unaudited pro forma historical revenue and certain operating expense information for the year ended December 31, 2025 are comprised of the
following (dollars in thousands):
Year ended December 31, 2025
Acquisitions
Revenues
Total Expenses
Midwest Portfolio
$
18,006
$
11,915
Addington Place of Cape Coral
8,267
6,383
Addington Place of Canfield
6,898
4,779
Discovery Portfolio
34,253
29,617
River Glen of St. Charles
9,006
6,465
Addington Place of Spirit Lake
4,615
3,775
Central IL Portfolio
9,924
7,438
Sonata Portfolio
15,094
9,031
Inspired Portfolio
32,175
23,642
Crestview Senior Living
5,070
3,323
Maine Portfolio
12,329
9,364
Total pro forma revenues and expenses
$
155,637
$
115,732
(3.C) Represents the removal of the historical revenues and
income of the Disposition for the nine months ended September 30, 2026 and for the year ended December 31, 2025.
(3.D) Reflects increase in rental revenues for straight line
rent amounts and amortization of acquired below-market leases resulting from purchase accounting under ASC 805 and ASC Topic 842, Leases.
(3.E) Represents the depreciation and amortization expense
adjustments for the nine months ended September 30, 2026 and the year ended December 31, 2025 (dollars in thousands):
Acquired real estate investments
Useful lives (years)
Nine months ended September 30, 2026
Year ended December 31, 2025
Site improvements
15
$
846
$
1,436
Furniture, fixtures and equipment
15
1,154
1,941
In-place leases
1
—
44,466
Building
40
7,159
12,078
Total pro forma depreciation and amortization
$
9,159
$
59,921
(3.F) Reflects the recognition of the gain on sale of $151.5 million as a result of the Disposition as calculated in Note 2.C, which is non-recurring in nature.
9
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 7
v3.26.3
Document and Entity Information
Nov. 10, 2026
Cover [Abstract]
Document Type
8-K
Amendment Flag
false
Document Period End Date
Nov. 10, 2026
Entity File Number
001-39153
Entity Registrant Name
National Healthcare Properties, Inc.
Entity Central Index Key
0001561032
Entity Incorporation, State or Country Code
MD
Entity Tax Identification Number
38-3888962
Entity Address, Address Line One
540 Madison Ave., 27th Floor
Entity Address, City or Town
New York
Entity Address, State or Province
NY
Entity Address, Postal Zip Code
10022
City Area Code
332
Local Phone Number
258-8770
Title of 12(b) Security
Common stock, $0.01 par value per share
Trading Symbol
NHP
Security Exchange Name
NASDAQ
Entity Emerging Growth Company
false
Written Communications
false
Soliciting Material
false
Pre-commencement Tender Offer
false
Pre-commencement Issuer Tender Offer
false
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Cover page.
+ References
No definition available.
+ Details
Name:
dei_CoverAbstract
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration